What is the most recent earnings date for CUE stock?
CUE BIOPHARMA INC (CUE) last reported earnings on 11/12/2025.
CUE BIOPHARMA INC (CUE) Earnings History & Surprises
NASDAQ:CUE • US22978P1066
Current stock price
0.2599 USD
-0.01 (-3.74%)
Last:
CUE Earnings overview
Past quarterly earnings results for CUE BIOPHARMA INC (CUE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Mar 24, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$0.10
- Revenue Estimate
- 2.525M
Last Reported
Most Recent- Release Date
- Nov 12, 2025
- Period
- Q3 / 2025
- EPS Reported
- -$0.07
- EPS Surprise
- 25.74%
- Revenue Surprise
- -7.09%
Beat Rate
Last 8 Quarters 69%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -0.07 | -0.09 | 25.74% | 58.82% | 2.149M | 2.313M | -7.09% | -35.58% |
| Q2 2025 | -0.09 | -0.14 | 36.35% | 55.00% | 2.954M | 2.419M | 22.12% | 11.14% |
| Q1 2025 | -0.17 | -0.15 | -9.77% | 32.00% | 421K | 1.28M | -67.11% | -75.48% |
| Q4 2024 | -0.13 | -0.16 | 17.49% | 55.17% | 1.576M | 1.718M | -8.27% | -13.45% |
| Q3 2024 | -0.17 | -0.19 | 12.56% | 29.17% | 3.336M | 1.535M | 117.33% | 58.86% |
| Q2 2024 | -0.20 | -0.29 | 30.27% | 31.03% | 2.658M | 1.302M | 104.15% | 92.33% |
| Q1 2024 | -0.25 | -0.28 | 12.23% | 13.79% | 1.717M | 1.225M | 40.16% | 818.18% |
| Q4 2023 | -0.29 | -0.28 | -3.28% | 23.68% | 1.821M | 1.583M | 15.03% | 1,114.00% |
| Q3 2023 | -0.24 | -0.35 | 30.62% | 22.58% | 2.1M | 1.144M | 83.57% | 2,900.00% |
| Q2 2023 | -0.29 | -0.31 | 5.86% | 21.62% | 1.382M | 916.575K | 50.78% | 4,506.67% |
| Q1 2023 | -0.29 | -0.29 | 0.99% | 34.09% | 187K | 1.97M | -90.51% | -81.30% |
| Q4 2022 | -0.38 | -0.31 | -21.37% | -52.00% | 150K | 104.788K | 43.15% | -98.18% |
| Q3 2022 | -0.31 | -0.38 | 19.23% | 24.39% | 70K | 444.733K | -84.26% | -97.08% |
| Q2 2022 | -0.37 | -0.43 | 13.46% | -12.12% | 30K | 1.143M | -97.38% | -98.91% |
| Q1 2022 | -0.44 | -0.43 | -1.90% | -7.32% | 1M | 3.085M | -67.59% | -35.48% |
| Q4 2021 | -0.25 | -0.39 | 35.71% | 30.56% | 8.25M | 2.996M | 175.37% | 1,618.75% |
| Q3 2021 | -0.41 | -0.39 | -4.09% | -20.59% | 2.4M | 1.884M | 27.39% | 242.86% |
| Q2 2021 | -0.33 | -0.42 | 21.46% | 13.16% | 2.74M | 1.068M | 156.55% | 153.70% |
| Q1 2021 | -0.41 | -0.38 | -7.39% | 14.58% | 1.55M | 591.456K | 162.07% | 72.22% |
| Q4 2020 | -0.36 | -0.35 | -1.84% | - | 480K | 1.346M | -64.34% | - |
| Q3 2020 | -0.34 | -0.39 | 12.33% | - | 700K | 1.712M | -59.11% | - |
| Q2 2020 | -0.38 | -0.43 | 11.68% | - | 1.08M | 2.108M | -48.77% | - |
| Q1 2020 | -0.48 | -0.35 | -35.79% | - | 900K | 1.852M | -51.40% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
17.45%
Max EPS beat (4)
36.35%
Min EPS beat (4)
-9.77%
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
-15.09%
Max Revenue beat (4)
22.12%
Min Revenue beat (4)
-67.11%
Analysis
In the last 4 quarters, CUE has beaten EPS estimates in 3 out of 4 releases
CUE has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, CUE has beaten the EPS estimates by 17.5% on average.
In the last 4 quarters, CUE reported -15.1% below the revenue estimates on average.
Related analysis
CUE BIOPHARMA INC / CUE Earnings FAQ
Can you provide information on whether CUE BIOPHARMA INC beat earnings estimates in the last quarter?
CUE BIOPHARMA INC (CUE) beat EPS estimates and missed revenue estimates in the most recent quarter.
What percentage of the time does CUE stock beat earnings estimates?
In the last 4 quarters, CUE BIOPHARMA INC (CUE) has beaten EPS estimates in 3 out of 4 releases.